Atlas Trials

A Study to Evaluate the Relative Bioavailability of AMG 510 Administered as Tablets and as a Water Dispersion in Healthy Participants

Clinical trial NCT05571163 · COMPLETED

Trial details

NCT number
NCT05571163
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2020-03-06
Primary completion
2020-06-14
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.